Growth Metrics

Evolent Health (EVH) Shares Outstanding (Weighted Average) (2016 - 2026)

Evolent Health has reported Shares Outstanding (Weighted Average) over the past 12 years, most recently at $114.2 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) changed 0.41% year-over-year to $114.2 million; the TTM value through Dec 2025 reached $114.2 million, changed 0.41%, while the annual FY2025 figure was $114.2 million, 0.41% changed from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $114.2 million at Evolent Health, down from $115.1 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $115.9 million in Q2 2025 and troughed at $84.7 million in Q1 2021.
  • A 5-year average of $103.2 million and a median of $110.0 million in 2023 define the central range for Shares Outstanding (Weighted Average).
  • Biggest five-year swings in Shares Outstanding (Weighted Average): increased 21.99% in 2023 and later decreased 0.41% in 2025.
  • Year by year, Shares Outstanding (Weighted Average) stood at $86.1 million in 2021, then rose by 8.87% to $93.7 million in 2022, then rose by 18.73% to $111.3 million in 2023, then grew by 3.08% to $114.7 million in 2024, then dropped by 0.41% to $114.2 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for EVH at $114.2 million in Q4 2025, $115.1 million in Q3 2025, and $115.9 million in Q2 2025.